Source link : https://www.newshealth.biz/health-news/high-deep-remission-rate-with-triple-regimen-for-relapsed-refractory-cll/
Time-limited treatment with a three-drug combination for relapsed/refractory chronic lymphocytic leukemia (CLL) produced long-term undetectable residual disease in more than 90% of patients, updated results from a prospective study showed. After a median follow-up of 36.3 months, 42 of 45 patients achieved undetectable measurable residual disease (uMRD) in peripheral blood (PB) at any time point […]
Author : News Health
Publish date : 2024-04-24 21:22:09
Copyright for syndicated content belongs to the linked Source.